Preclinical Study of CDH3-Targeted 89 Zr/ 177 Lu Theranostics in Triple-Negative Breast Cancer

Molecular Pharmaceutics 2026 Open access

Read full text
Authors: Mingming Tang, Huayan Zhang, Huan Du, Xiaofei Hao, Binwei Lin, Yihan Zhu, Decai Wang, Wei Wu, Xiaobo Du
DOI: 10.1021/acs.molpharmaceut.5c01584
Cited by: 2
References: 45

Abstract

Lu-11E10C11 dual-functional probe successfully achieved an integrated "diagnosis-therapy" strategy, offering a novel approach with translational potential for precision management of TNBC.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications HER2/EGFR in Cancer Research Wnt/β-catenin signaling in development and cancer

Publication details

Journal / source
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Volume
23
Issue
2
Pages
1213–1223
Publication date
22 January 2026
Language
EN